2020 NASPGHAN意见书：内镜超声和ERCP在儿童慢性胰腺炎评估和治疗中的作用

2020-04-01 北美小儿胃肠病、肝脏病和营养学会 J Pediatr Gastroenterol Nutr. 2020 May;70(5):681-693.

2020年4月，北美小儿胃肠病、肝脏病和营养学会(NASPGHAN)发布了关于内镜超声和ERCP在儿童慢性胰腺炎评估和治疗中的作用的意见书。儿童慢性胰腺炎的诊断越来越多，内镜超声和ERCP在慢性胰腺炎

中文标题：

英文标题：

The Roles of Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography in the Evaluation and Treatment of Chronic Pancreatitis in Children: A Position Paper From the North American Society for Pediatric Gastroenterology,

发布机构：

北美小儿胃肠病、肝脏病和营养学会

发布日期：

2020-04-01

简要介绍：

2020年4月，北美小儿胃肠病、肝脏病和营养学会(NASPGHAN)发布了关于内镜超声和ERCP在儿童慢性胰腺炎评估和治疗中的作用的意见书。儿童慢性胰腺炎的诊断越来越多，内镜超声和ERCP在慢性胰腺炎的诊断和管理中是一种有用的工具。本文主要介绍了内镜超声和ERCP在儿童慢性胰腺炎评估和治疗中的作用，指出内镜超声和ERCP可安全用于儿童慢性胰腺炎的诊断并可辅助治疗慢性胰腺炎相关并发症。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=a093b1c001899ec9, title=2020 NASPGHAN意见书：内镜超声和ERCP在儿童慢性胰腺炎评估和治疗中的作用, enTitle=The Roles of Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography in the Evaluation and Treatment of Chronic Pancreatitis in Children: A Position Paper From the North American Society for Pediatric Gastroenterology, , guiderFrom=J Pediatr Gastroenterol Nutr. 2020 May;70(5):681-693., authorId=0, author=, summary=2020年4月，北美小儿胃肠病、肝脏病和营养学会(NASPGHAN)发布了关于内镜超声和ERCP在儿童慢性胰腺炎评估和治疗中的作用的意见书。儿童慢性胰腺炎的诊断越来越多，内镜超声和ERCP在慢性胰腺炎, cover=https://img.medsci.cn/202052/1588429672777_2020535.jpg, journalId=0, articlesId=null, associationId=99, associationName=北美小儿胃肠病、肝脏病和营养学会, associationIntro=北美小儿胃肠病、肝脏病和营养学会（North American Society for Pediatric Gastroenterology, Hepatology and Nutrition，NASPGHAN）有1400多成员组成，其主要分布在美国、哥伦比亚、波罗黎各、墨西哥和加拿大等国。其专注于儿童及青少年胃肠疾病、肝脏疾病以及营养疾病。旗下有一本专业期刊《Journal of Pediatric Gastroenterology and Nutrition》。, copyright=0, guiderPublishedTime=Wed Apr 01 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年4月，北美小儿胃肠病、肝脏病和营养学会(NASPGHAN)发布了关于内镜超声和ERCP在儿童慢性胰腺炎评估和治疗中的作用的意见书。儿童慢性胰腺炎的诊断越来越多，内镜超声和ERCP在慢性胰腺炎的诊断和管理中是一种有用的工具。本文主要介绍了内镜超声和ERCP在儿童慢性胰腺炎评估和治疗中的作用，指出内镜超声和ERCP可安全用于儿童慢性胰腺炎的诊断并可辅助治疗慢性胰腺炎相关并发症。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=1021, tagName=胰腺炎), TagDto(tagId=3015, tagName=ERCP), TagDto(tagId=56808, tagName=内镜超声)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=14127, guiderKeyword=慢性胰腺炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2542, appHits=39, showAppHits=16, pcHits=245, showPcHits=2558, likes=0, shares=2, comments=9, approvalStatus=1, publishedTime=Sat May 02 22:36:47 CST 2020, publishedTimeString=2020-04-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 02 22:30:48 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 04:45:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 NASPGHAN意见书：内镜超声和ERCP在儿童慢性胰腺炎评估和治疗中的作用.pdf)])

2020 NASPGHAN意见书：内镜超声和ERCP在儿童慢性胰腺炎评估和治疗中的作用.pdf

下载请点击：

评论区 (9)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=804453, encodeId=9e6380445375, content=高发, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:21 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804452, encodeId=65d1804452b5, content=最近, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:11 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804451, encodeId=24fb80445121, content=胰腺炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:08 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804450, encodeId=8e3c8044508b, content=儿童, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:03 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804449, encodeId=d6f480444999, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:46:58 CST 2020, time=2020-07-25, status=1, ipAttribution=)]
2020-07-25 ms7000001691666476

高发

127 0
[GetPortalCommentsPageByObjectIdResponse(id=804453, encodeId=9e6380445375, content=高发, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:21 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804452, encodeId=65d1804452b5, content=最近, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:11 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804451, encodeId=24fb80445121, content=胰腺炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:08 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804450, encodeId=8e3c8044508b, content=儿童, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:03 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804449, encodeId=d6f480444999, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:46:58 CST 2020, time=2020-07-25, status=1, ipAttribution=)]
2020-07-25 ms7000001691666476

最近

113 0
[GetPortalCommentsPageByObjectIdResponse(id=804453, encodeId=9e6380445375, content=高发, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:21 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804452, encodeId=65d1804452b5, content=最近, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:11 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804451, encodeId=24fb80445121, content=胰腺炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:08 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804450, encodeId=8e3c8044508b, content=儿童, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:03 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804449, encodeId=d6f480444999, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:46:58 CST 2020, time=2020-07-25, status=1, ipAttribution=)]
2020-07-25 ms7000001691666476

胰腺炎

110 0
[GetPortalCommentsPageByObjectIdResponse(id=804453, encodeId=9e6380445375, content=高发, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:21 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804452, encodeId=65d1804452b5, content=最近, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:11 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804451, encodeId=24fb80445121, content=胰腺炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:08 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804450, encodeId=8e3c8044508b, content=儿童, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:03 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804449, encodeId=d6f480444999, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:46:58 CST 2020, time=2020-07-25, status=1, ipAttribution=)]
2020-07-25 ms7000001691666476

儿童

122 0
[GetPortalCommentsPageByObjectIdResponse(id=804453, encodeId=9e6380445375, content=高发, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:21 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804452, encodeId=65d1804452b5, content=最近, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:11 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804451, encodeId=24fb80445121, content=胰腺炎, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:08 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804450, encodeId=8e3c8044508b, content=儿童, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:47:03 CST 2020, time=2020-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804449, encodeId=d6f480444999, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:46:58 CST 2020, time=2020-07-25, status=1, ipAttribution=)]
2020-07-25 ms7000001691666476

积分

115 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

消化指南

2020 NASPGHAN意见书：内镜超声和ERCP在儿童慢性胰腺炎评估和治疗中的作用

相关指南

拓展阅读

科室

工具

服务